Frost & Sullivan: AI, biologics and supply resilience redefine pharma growth through 2031
June 11, 2026 | 12:02
New Frost & Sullivan analysis reveals the global pharmaceutical industry is undergoing a high-stakes reset, with future winners expected to be those that can execute faster, industrialize innovation, and navigate mounting pricing and geopolitical pressures through 2031.
Latest News
Mobile Version